Skip to main content

Day: July 24, 2020

Sterke groei van de EBITDAaL houdt stand, in lijn met de ambitie voor het volledige jaar

PersberichtEmbargo tot 24 juli 2020 om 7.00 u.Gereglementeerde informatieFinanciële informatie voor het tweede kwartaal van 2020 en het eerste halfjaar van 2020Sterke groei van de EBITDAaL houdt stand, in lijn met de ambitie voor het volledige jaarHet aantal mobiele postpaidklanten stijgt met +3,1% j-o-j dankzij 7 duizend nettotoevoegingen in het afgelopen kwartaal Het aantal convergente klanten stijgt met +33,6% j-o-j dankzij 8 duizend nettotoevoegingen in het afgelopen kwartaalOmzet in Kw21: -7,9% j-o-j / Omzet uit retaildiensten in Kw21: +2,1% j-o-jEBITDAaL in Kw21: +9,7% j-o-jDe vooruitzichten voor de EBITDAaL blijven ongewijzigdCOVID-19De coronamaatregelen hebben een impact gehad op de commerciële prestaties. Door de sluiting van de winkels tot midden mei werden er minder nieuwe convergente en mobiele klanten geworven. Bijgevolg...

Continue reading

L’EBITDAaL continue de croître, en ligne avec l’objectif pour l’exercice

Communiqué de presseEmbargo jusqu’au vendredi 24 juillet 2020 à 7h00Information réglementéeInformation financière relative au deuxième trimestre et au premier semestre 2020L’EBITDAaL continue de croître, en ligne avec l’objectif pour l’exerciceCroissance de +3,1% de la base clients mobiles postpayés en glissement annuel, soit un ajout net de 7 000 contrats sur le trimestreProgression de +33,6% de la base clients convergents en glissement annuel, soit un ajout net de 8 000 clients sur le trimestrePour le T2, le chiffre d’affaires1 recule de -7,9%, et les services facturés au client1 progressent de +2,1% en glissement annuelL’EBITDAaL1  s’améliore de +9,7% au T2 en glissement annuelObjectif d’EBITDAaL inchangéPandémie de COVID-19Les mesures contre le COVID-19 ont une incidence sur la performance commerciale....

Continue reading

Cavotec SA – Interim report January – June 2020

Resilient profitability and cashflow despite lower revenueAPRIL–JUNE 2020  Revenues decreased -18.2% to EUR 42.0 million (51.4). Ports & maritime decreased -2.8%, Airports & Industry decreased -28.4% EBIT increased to EUR 2.8 million (2.5), corresponding to a margin of 6.6% (4.8%) Net result for the period was EUR 0.2 million (1.4)  Earnings per share basic and diluted amounted to EUR 0.002 (0.015) Operating cash flow amounted to EUR 2.3 million (-10.7) Net debt amounted to EUR 22.1 million (Q1 2020: 22.5) Order backlog decreased -7.9% compared to the previous quarter to EUR 98.2 million JANUARY–JUNE 2020  Revenues decreased -19.2% to EUR 80.7 million (99.8) EBIT decreased to EUR 3.6 million (3.9), corresponding to a margin of 4.5% (3.9%) Net result for the period was EUR 2.2 million (2.2)  Earnings per share basic and diluted...

Continue reading

Half-year financial report January – June 2020: Comparable operating profit improved in all segments despite lower net sales impacted by COVID-19 in Q2

Uponor Corporation     Half year financial report     24 July 2020      08:00 EETHalf-year financial report January – June 2020: Comparable operating profit improved in all segments despite lower net sales impacted by COVID-19 in Q2April–June 2020Net sales were €277.1 (292.6) million, a decline of 5.3%. Organic growth was -5.3% in constant currency terms.Comparable operating profit was €36.2 (25.3) million, a growth of 43.0%.Operating profit was €30.3 (25.3) million, a growth of 19.8%.Earnings per share were €0.21 (0.18).January–June 2020Net sales were €554.5 (541.5) million, a growth of 2.4%. Organic growth was 2.4% in constant currency terms.Comparable operating profit was €65.6 (39.5) million, a growth of 65.8%.Operating profit was €58.8 (39.5) million, a growth of 48.8%.Earnings per share were €0.51 (0.29).Cash flow from business...

Continue reading

Puolivuosikatsaus tammi-kesäkuu 2020: Vertailukelpoinen liikevoitto parani kaikissa segmenteissä toisella neljänneksellä COVID-19:n johdosta laskeneesta liikevaihdosta huolimatta

Uponor Oyj     Puolivuosikatsaus     24.7.2020     8.00Puolivuosikatsaus tammi-kesäkuu 2020: Vertailukelpoinen liikevoitto parani kaikissa segmenteissä toisella neljänneksellä COVID-19:n johdosta laskeneesta liikevaihdosta huolimattaHuhti–kesäkuu 2020Liikevaihto oli 277,1 (292,6) milj. euroa, laskua 5,3 prosenttia. Valuuttakurssivaikutukset huomioiden orgaaninen kasvu oli -5,3 prosenttia.Vertailukelpoinen liikevoitto oli 36,2 (25,3) milj. euroa, kasvua 43,0 prosenttia.Liikevoitto oli 30,3 (25,3) milj. euroa, kasvua 19,8 prosenttia.Osakekohtainen tulos oli 0,21 (0,18) euroa.Tammi–kesäkuu 2020Liikevaihto oli 554,5 (541,5) milj. euroa, kasvua 2,4 prosenttia. Valuuttakurssivaikutukset huomioiden orgaaninen kasvu oli 2,4 prosenttia.Vertailukelpoinen liikevoitto oli 65,6 (39,5) milj. euroa, kasvua 65,8 prosenttia.Liikevoitto oli 58,8 (39,5)...

Continue reading

Signify reports second quarter sales of EUR 1.5 billion, maintains operational profitability of 9.0% and generates a free cash flow of EUR 158 million

Press ReleaseJuly 24, 2020Signify reports second quarter sales of EUR 1.5 billion, maintains operational profitability of 9.0% and generates a free cash flow of EUR 158 millionSecond quarter 20201 – Demonstrating resilience in a challenging market environmentSignify’s installed base of connected light points increased from 61 million in Q1 20 to 64 million2 in Q2 20Sales of EUR 1,469m, nominal sales growth of -0.6% and CSG of -22.5%LED-based sales represented 80% of total sales (Q2 19: 79%3)Adj. indirect costs down EUR 86 million, or -19.1%, excl. currency effects and changes in scopeAdj. EBITA margin remained stable at 9.0%, including currency impact of -60 bpsAdj. EBITA margin of the growing profit engines increased by 100 bps to 9.5%Net income increased to EUR 81 million (Q2 19: EUR 50 million) mainly due to one-off itemsFree cash...

Continue reading

ADOPTION OF RESOLUTIONS OF THE GENERAL MEETING OF SHAREHOLDERS OF AS BATIKA WITHOUT CONVENING THE MEETING

The Management Board of AS Baltika, registry code 10144415, address Veerenni 24, Tallinn 10135 proposes to the shareholders to adopt resolutions of the shareholders without convening a meeting pursuant to § 2991 of the Commercial Code. The proposal to adopt resolutions without convening a general meeting of shareholders is for the convenience of shareholders and to avoid gatherings due to COVID-19 pandemic.Any questions of shareholders relating to the resolutions proposed can be sent in advance to the e-mail baltika@baltikagroup.com until 7th August 2020 and answers to all relevant questions will be made public on website of AS Baltika on www.baltikagroup.com.The list of shareholders entitled to vote the shareholders’ resolutions will be fixed on 7th August 2020 at the end of the business day of the NASDAQ CSD settlement system.Resolutions...

Continue reading

AS BALTIKA AKTSIONÄRIDE ÜLDKOOSOLEKU OTSUSTE VASTUVÕTMINE KOOSOLEKUT KOKKU KUTSUMATA

Aktsiaselts BALTIKA, registrikood 10144415, asukohaga Veerenni 24, Tallinn 10135 juhatus teeb aktsionäridele ettepaneku aktsionäride otsuste vastuvõtmiseks ilma koosolekut kokku kutsumata vastavalt äriseadustiku §-le 2991. Ettepanek otsuste vastuvõtmiseks ilma aktsionäride üldkoosolekut kokku kutsumata on aktsionäride mugavuseks ja et vältida kogunemisi COVID-19 pandeemia ajal.  Otsustamisele pandavate ettepanekute osas tekkivad küsimused saab saata ette e-mailile baltika@baltikagroup.com kuni 7. August 2020 ja vastused asjakohastele küsimustele avalikustatakse AS Baltika kodulehel www.baltikagroup.com.Aktsionäride otsuste hääletamiseks hääleõiguslike aktsionäride nimekiri fikseeritakse 7. Augusti 2020 Nasdaq CSD arveldussüsteemi tööpäeva lõpu seisuga.Aktsionäride otsuseid on võimalik hääletada perioodil 10. August kuni 16. August 2020...

Continue reading

RedHill Biopharma beschleunigt mit der Ausweitung auf Brasilien und Mexiko COVID-19-Programm der Phase II/III

Verfahren für Studie der Phase II/III in Brasilien und Mexiko eingeleitet Die globale Studie der Phase II/III mit Opaganib für die Behandlung von schwer erkrankten COVID-19-Patienten wurde im Vereinigten Königreich und in Russland bereits genehmigt Patientenrekrutierung beginnt voraussichtlich in diesem Monat – 270 Probanden sollen an bis zu 40 Prüfzentren in die Studie aufgenommen werden Mögliche Einreichung von Anträgen für den Einsatz in Härtefällen für das vierte Quartal 2020 geplant Rekrutierung für die parallel in den USA durchgeführte Studie der Phase II bei schwerer COVID-19-Erkrankung wird voraussichtlich im August abgeschlossenTEL-AVIV, Israel und RALEIGH, N.C., July 24, 2020 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (Nasdaq: RDHL) („RedHill“ oder das „Unternehmen“), ein spezialisiertes biopharmazeutisches Unternehmen,...

Continue reading

Equinor ASA: Information relating to dividend for second quarter 2020

Key information relating to the cash dividend to be paid by Equinor (OSE: EQNR, NYSE: EQNR) for second quarter 2020.Dividend amount: 0.09Declared currency: USDLast day including rights: 11 November 2020Ex-date: 12 November 2020Record date: 13 November 2020Payment date: 25 November 2020Other information: Dividend per share in NOK will be communicated 19 November 2020This information is published in accordance with the requirements of the Continuing Obligations.This information is subject to the disclosure requirements pursuant to Section 5-12 in the Norwegian Securities Trading Act

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.